María José Abud

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are used by pharmaceutical originator companies in the U.S. and(More)
  • 1